Purpose: Bone is a preferential site of breast cancer metastasis, and models are needed to study this process at the level of the microenvironment. We have used bioluminescence imaging (BLI) and multiplex biomarker immunoassays to monitor dynamic breast cancer cell behaviors in co-culture with human bone tissue. Procedures: Femur tissue fragments harvested from hip replacement surgeries were co-cultured with luciferase-positive MDA-MB-231-fLuc cells. BLI was performed to quantify breast cell proliferation and track migration relative to bone tissue. Breast cell colonization of bone tissues was assessed with immunohistochemistry. Biomarkers in co-culture supernatants were profiled with MILLIPLEX ® immunoassays.
Introduction

B
one is a frequent site of metastasis in breast cancer patients, and the development of informative models to study skeletal metastasis remains an ongoing challenge [1, 2] . Although in vivo mouse models enable study of the metastatic process within the context of whole body physiology, drawbacks include the prolonged time course and relative inefficiency of metastatic colonization of human breast cancer cells into the murine skeletal system, coupled with the inability to perturb and monitor detailed events at the cellular level within the microenvironment [3] [4] [5] [6] . In vitro models based on the co-culture of breast cancer cells with bone marrow-derived stromal cells or osteoblasts facilitate the analysis of specific cell interactions, but exclude many critical components of the bone microenvironment [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Bone is a complex tissue, encompassing ossified bone and marrow compartments that house multiple cell types contributing to the metastatic niche [18, 19] . Additional approaches are needed that will provide direct access to these compartments and enable the rapid quantification of dynamic interactions within them. We have established an optical imaging approach to monitor the dynamics of luciferase-expressing human breast cancer cells (MDA-MB-231-fLuc) co-cultured with human bone fragments isolated from discarded total hip replacement (THR) surgical specimens. Here we describe the use of serial bioluminescence imaging (BLI) to quantify breast cancer cell proliferation, track breast cell migration toward bones, and monitor breast cell colonization of bone tissue over time, revealing highly consistent behaviors. Because the cell-tissue interactions occur over relatively short periods of time (hours to days), the immediate quantitation afforded by BLI provides a rapid readout of cell function, enabling the direct, rapid study of dynamic processes within the metastatic niche. These cocultures also provide ready access to factors, cells, and tissues for analysis, including quantification of protein biomarkers in co-culture supernatants by MILLIPLEX ® MAP magnetic bead immunoassays and postculture immunohistochemical staining. Our work demonstrates the utility of using human bone tissues in a co-culture model to characterize and target breast cancer cell behaviors within the three-dimensional architecture of the native metastatic niche.
Methods
Human Femur Tissue
Femoral heads were collected from patients undergoing elective THR in the Department of Orthopaedic Surgery at the Stanford University Medical Center. All tissues were collected as deidentified specimens in accordance with the Stanford University Research Compliance Office. Discarded femoral head specimens were transported to the lab within 1-2 h of surgery, and placed into a Pyrex dish (VWR, Radnor, PA) (Fig. 1a) . Using a sterile glove to hold the femoral head with one hand, cancellous bone fragments measuring ∼3-5 mm 2 were dissected from the shaft using a surgical rongeur (Fine Science Tools, Foster City, CA) for placement into co-culture experiments. Viability of the marrow compartment was determined by trypan blue exclusion at time 0, 24, 48, and 72 h following marrow depletion of bone fragments isolated from three patient specimens (THR 23, 24, and 25), as described below.
Breast Cancer Cells
MDA-MB-231 breast cancer cells were purchased from the American Type Culture Collection (ATCC; Rockville, MD) and engineered for the stable expression of firefly luciferase using the Sleeping Beauty transposon plasmid pKT2/PGK-BSD:GFP_CLP-Luc (MDA-MB-231-fLuc). The original transposon was kindly provided by Drs. Scott McIvor, Univ. of Minnesota, Minneapolis, MN, and Andrew Wilber, Department of Surgery and Simmons Cancer Institute, Southern Illinois Univ. School of Medicine, Springfield, IL, and further modified in our laboratory to express the luciferase reporter and enhanced green fluorescence protein (eGFP) [20] .
Co-cultures
Co-cultures were performed in six-well cell culture plates (Corning, Inc., NY, USA) by seeding breast cancer cells adjacent to bone fragments immobilized by bone wax (Surgical Specialties Corporation, Reading, PA) (Fig. 1b) . A small (35 mg) piece of bone wax was affixed at the 12 o′clock position of all experimental and control wells as shown in Fig. 1b 
Bone Marrow Depletion
For some comparisons, the marrow was flushed from the bone fragments by agitating them in three successive Petri dishes containing phosphate-buffered saline (PBS). During each rinse, individual bone fragments were immobilized with a pair of tweezers and flushed with PBS using a 10-ml syringe and 27-guage needle until most of the red coloration disappeared (Fig. 1d ). Fig. 1e shows an experimental plate containing marrow-intact fragments (top row) and marrow-depleted fragments (bottom row).
Optical Imaging
Bioluminescence imaging was performed on co-culture plates in an IVIS 50 Imaging Platform (Caliper Life Sciences, Inc., Hopkinton, MA) immediately following addition of luciferin substrate (300 μg/ ml) to all wells at time 0, 24, 48, 72, and 96 h. Imaging parameters were f-stop of 1, small binning, level D, and 1 s exposure, and signal intensity was measured as average radiance (photons/second/ square centimeter/steradian). Average radiance was measured and quantified for all individual wells designated as regions of interest (ROI) within each plate using the Living Image Software Program (version 4.3.1).
Culture Supernatant Protein Biomarker Analysis
Multiplex immunoassays were performed on 24-h and 48-h supernatants collected from (1) breast cell cultures, bone tissue cultures, and breast/bone co-cultures in six-well plates and (2) 24-h cultures of intact vs. marrow-depleted bone fragments in 24-well plates. Aliquots of 0.5 ml of conditioned media were collected into microfuge tubes and centrifuged for 5 min at 13,000 rpm on a tabletop microcentrifuge at room temperature (RT). Supernatants from these centrifugations were stored at −80°C until analysis. Supernatants were analyzed using MILLIPLEX ® MAP magnetic bead immunoassay kits (EMD Millipore, Billerica, MA) based on the Luminex ® xMAP ® technology. Protein biomarkers in breast/bone supernatants were quantitatively determined using 
Histological Processing
Bone tissue fragments were fixed in 10 % buffered formalin, decalcified, and processed for paraffin embedding and slide preparation. Tissue sections were stained with hematoxylin and eosin (H&E) or processed for immunohistochemical analysis using a monoclonal mouse anti-human cytokeratin antibody (Clone AE1/AE3) (Dako Cytomation, Carpenteria, CA). 
Statistical Analysis
Imaging data are expressed as average radiance (photons/second/ square centimeter/steradian) ±SE. Values across co-culture conditions (bone vs. no bone and marrow intact vs. marrow depleted) were compared using a one-tailed Student's t test. pG0.05 was considered to be statistically significant.
Results
Growth of MDA-MB-231-fLuc Cells in Co-cultures
MDA-MB-231-fLuc cell proliferation in the presence vs. absence of bone tissues was determined by levels of luciferase activity in each well. A reproducibly higher BLI signal (indicating higher cell numbers) was observed when breast cancer cells were co-cultured with bone, as shown in Fig. 1c . While BLI signal was equivalent at time 0 (Fig. 2c) , reflecting uniform breast cell seeding, quantitative BLI analysis at 24 h confirmed significantly increased luciferase activity from breast cells in the presence vs. absence of bones, as illustrated for THR specimens 2, 3, and 4 in Fig. 2a (pG0.001) . As shown in Fig. 2b , MDA-MB-231-fLuc cell proliferation was also significantly greater, as assessed by bioluminescent signal intensity, in the presence of intact vs. marrow-depleted bone fragments in co-cultures with THR specimens 5, 9 (pG0.05), and 10 (pG0.01). Increased cell proliferation in the presence of bone fragments was observed in co-cultures maintained with, and without, regular media changes. Fig. 2d shows quantitative analysis of BLI generated by co-cultures with THR specimens 13 and 14 at 48 h, illustrating growth enhancement patterns in cultures with (+) and without (−) media change at 24 h.
Migration of MDA-MB-231-fLuc Cells Toward Bone Fragments
BLI of co-culture dishes suggested the directed migration of MDA-MB-231-fLuc cells toward the bone fragments, as shown in Fig. 1g , Fig. 1g shows BLI of THR specimen 11 at 48 h, and Fig. 1h shows BLI of THR specimen 11 at 96 h illustrating dramatic relocation of signal from the central location of the plastic dish to the 12 o′clock position harboring the bone fragments in two of the three wells. 
Histology of Bone Fragments and Immunohistochemical Analysis of Co-cultures
H&E staining of bone fragment tissue sections at time 0 revealed typical cancellous bone architecture consisting of a lattice of ossified bone spicules (with associated osteocytes, and osteoblasts and osteoclasts) throughout the marrow compartment (Fig. 3a) . Marrow cells including hematopoietic (red and white blood cell progenitors) and stromal cells (with numerous adipocytes) were present within the lattice of (Fig. 3a) and onto ossified bone surfaces (Fig. 3b) .
Viability of Bone Marrow Compartment
Average viabilities observed for marrow cells flushed from bone fragments originating from three separate patient specimens were 72.3 % (time 0), 69.5 % (24 h), 69.6 % (48 h), and 63.9 % (72 h).
MILLIPLEX ® Analysis
Analysis of supernatants demonstrated the presence of boneassociated growth factors, cytokines, and chemokines in cultures of bone alone, but at lower levels in most cultures of breast cells alone. In many cases, the levels of these factors were higher when bones were co-cultured with breast cancer cells, as illustrated in Fig. 4 . Comparison of a panel of factors in supernatants collected from intact vs. marrow-depleted bone fragments revealed dramatic reductions in the levels of many cytokines, chemokines, and growth factors as shown in Fig. 5 .
Discussion
Breast Cancer Metastasis
Most breast cancers originate from the epithelial cells lining the ductal-alveolar structures of the mammary gland in a series of steps characterized by localized proliferation. The metastatic process unfolds when breast cells invade the surrounding stroma, gain access to blood or lymphatic vessels, and survive transit through the circulation to extravasate into distant organs to seed micrometastatic colonies. The most common site of distant breast cancer metastatic spread is bone [1, 2] , and the presence of rare disseminated tumor cells (DTCs) in bone marrow aspirates at initial diagnosis is associated with poor prognosis [21] [22] [23] [24] [25] [26] . Micrometastatic cells have the capacity to remain dormant for many years and harbor varying potential for generating clinically detectable metastatic disease [27] [28] [29] , which involves extensive breast cancer cell colonization of the skeleton through complex interactions with bone cells. These interactions include the release of breast cancer cell factors that stimulate osteoclasts to degrade mineralized bone matrix, leading to the release of factors that stimulate breast cancer cell growth in what has been termed the "vicious cycle of metastasis" [30] , and fueling malignant cell growth along with the widespread destruction of bone tissue, disruption of mineral homeostasis, pain, and fractures.
Bone Tissue Co-culture Model
The co-culture of viable bone tissues with cancer cells offers a model system for characterizing and targeting these interactions within the three-dimensional architecture of the native bone microenvironment, and others have demonstrated the utility of this approach using mouse bones. Schiller et al. developed a model in which whole neonatal mouse femurs were co-cultured with a variety of mouse and human cancer cell lines, demonstrating bone tissue viability and illustrating synergistic paracrine interactions between intact bone and tumor cells with enzyme-linked immunosorbent assay (ELISA) [31] . Curtin et al. developed a roller tube model system to co-culture mouse calvarial bones with breast and prostate cancer cell lines to demonstrate cancer cell colonization of the endosteal bone surfaces and subsequent promotion of osteoclast activity resulting in bone resorption [32] . Others have cultured mouse bones harvested from breast cancer xenograft models to examine cytokine production of mouse bones colonized by breast cancer cells [17, 33] . These mouse studies demonstrate the feasibility of bone co-culture models to simulate the microenvironment and study dynamic cell interactions within the bone metastatic niche. However, Kuperwasser et al. demonstrated that human breast cancer cells preferentially home to human bone fragments implanted in mice, suggesting species-specific osteotropism and reinforcing the need to study these interactions in human bone tissues [5] .
We have developed a co-culture model using human bone tissue isolated from total hip replacement surgery specimens and have established proof of principle for using optical Fig. 5 . Protein biomarker levels attenuated by bone marrow depletion. Three THR specimens (9, 10, and 11) were used for the comparison of biomarker levels in supernatants from cultures with intact (blue bars) vs. marrow-depleted (red bars) bone fragments at 24 h using MILLIPLEX ® analysis. Results are shown for eight biomarkers including macrophage migration inhibitory factor (MIF), sFAS, monocyte-specific chemokine 3 (MCP-3), hepatocyte growth factor (HGF), fibroblast growth factor 2 (FGF-2), neuron-specific enolase (NSE), YKL40, and TNF-related weak inducer of apoptosis (TWEAK) demonstrating twofold or greater attenuation following marrow depletion. Each bar represents the average of duplicate analyses of a given supernatant/bone fragment/well for THR specimens 9 and 10 and three of the analytes measured for THR 11 (MIF, sFAS, and MCP-3). The remaining analytes measured for THR 11 samples were single measurements.
imaging approaches to monitor the dynamics of luciferasepositive human breast cancer cells (MDA-MB-231-fLuc) cocultured with them. Serial BLI was performed to quantify breast cancer cell growth, track breast cell migration toward bones, and monitor breast cell colonization of bone tissue over time. We observed consistent patterns of breast cancer cell behavior indicating that novel interventions that disrupt this behavior could be readily studied in this model. MDA-MB-231-fLuc cell proliferation was reproducibly increased by the presence of bone fragments, and depletion of the marrow compartment resulted in reduced breast cell proliferation. MDA-MB-231-fLuc cell migration toward bone fragments was also observed with BLI, and breast cancer cell colonization of bone tissues was confirmed with immunohistochemical staining, which revealed cytokeratinpositive breast cancer cells within the marrow and ossified compartments. Interestingly, the MDA-MB-231-fLuc cells were often seen nestled specifically between the adipose cells of the marrow, resembling patterns reported for metastatic ovarian cancer cells within the omentum [34] .
The breast cancer cell behaviors observed with BLI suggested mediation by paracrine interactions. To determine if we could detect bone-associated factors in our co-culture supernatants, we used previously established MILLIPLEX ® panels for bone, cytokine, cancer, metastasis, and angiogenesis markers. This broad interrogation revealed the presence of bone-associated factors, including osteocalcin (secreted by osteoblasts), osteopontin (OPN, synthesized by osteoblasts and osteocytes), tartrate-resistant acid phosphatase 5 (TRAP 5, produced by osteoclasts), and interleukin-6 (IL-6, produced by osteoblasts). Interestingly, we detected high levels of osteoprotegerin (OPG) in supernatants from breast cells cultured in the absence of bone. OPG is a member of the tumor necrosis factor receptor (TNFR) superfamily, secreted by osteoblasts to inhibit osteoclast formation. Along with receptor activator of nuclear-κβ (RANK) and RANK ligand (RANKL), which regulate osteoclast activation and bone turnover, OPG is also produced by the mammary gland to regulate calcium release from the skeleton during lactation [35] [36] [37] , and its expression has been reported in breast tissues and breast cancer cell lines, including MDA-MB-231 cells [35, 38, 39] .
Analysis of supernatants revealed the upregulation of bone-associated factors in the presence of breast cancer cells, suggesting active crosstalk during co-culture. Depletion of the marrow compartment resulted in reduced breast cell proliferation, in keeping with dramatic reductions in the levels of cytokines, chemokines, and growth factors in the co-culture supernatants, as detected by MILLIPLEX ® analysis. Because there is considerable overlap between the constellation of cytokines, chemokines, and growth factors that mediate cancer progression and wound healing, it is possible that factors released in response to the surgical removal of bone tissues could mediate some of the observed responses. However, we observed differential growth responses with serial BLI through 96 h of culture, even when tissue culture media were replaced at 24-h intervals, suggesting the active production and release of factors during culture. Our preliminary secretome analysis establishes proof of principle for future mechanistic studies of paracrine interactions in our co-culture model.
Study Limitations
Thus far, we have studied cancer cell/bone interactions during relatively short time periods for up to 96 h, and our co-culture model has not yet been defined and optimized for extended bone viability. In keeping with other reports, we observed a decline in marrow viability after 48 h as revealed by trypan blue exclusion measurement and appearance in histologic section [31] . An important next step will involve the systematic optimization of conditions for long-term culture. In addition, although blood vessels are present throughout the bone tissue, potentially enabling angiocrine interactions [40] , the lack of a functioning circulatory system prevents the study of breast cell extravasation with this model.
Conclusions
The proximal femur is a common site of breast cancer metastasis [41] , and total hip replacement surgeries constitute a valuable, renewable source of nondiseased tissues from this region for modeling in co-culture. These specimens harbor both the marrow and ossified compartments necessary to study mechanisms underlying micrometastasis, as well as clinically detectable metastatic disease. The specimens in this study originated from both male and female patients of various ages, both of which may contribute to the variability observed across specimens. However, BLI has revealed highly reproducible patterns of breast cell/bone tissue interactions within these cultures, consistently demonstrating enhanced breast cell proliferation in the presence vs. absence of bone, and attenuation of signal following bone marrow depletion. Because of the accelerated time course of interactions and the immediate quantitation afforded by BLI, this approach enables the direct, rapid study of dynamic processes within a simulated metastatic niche. This approach circumvents the prolonged time course associated with in vivo metastasis models, offering the potential for high-throughput perturbation of specific targets to identify and evaluate therapeutic interventions to prevent and treat bone metastasis.
